SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Magne F., Hachelaf W., Suau A., Boudraa G., Mangin I., Touhami M., Bouziane-Nedjadi K., Pochart P. (2006) A longitudinal study of infant faecal microbiota during weaning. FEMS Microbiol Ecol 58:56371.
  • 2
    Penders J., Thijs C., Vink C., Stelma F.F., Snijders B., Kummeling I., van den Brandt P.A., Stobberingh E.E. (2006) Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 118:51121.
  • 3
    Qin J., Li R., Raes J., Arumugam M., Burgdorf K.S., Manichanh C., Nielsen T., Pons N., Levenez F., Yamada T., Mende D.R., Li J., Xu J., Li S., Li D., Cao J., Wang B., Liang H., Zheng H., Xie Y., Tap J., Lepage P., Bertalan M., Batto J.M., Hansen T., Le Paslier D., Linneberg A., Nielsen H.B., Pelletier E., Renault P., Sicheritz-Ponten T., Turner K., Zhu H., Yu C., Li S., Jian M., Zhou Y., Li Y., Zhang X., Li S., Qin N., Yang H., Wang J., Brunak S., Doré J., Guarner F., Kristiansen K., Pedersen O., Parkhill J., Weissenbach J., MetaHIT Consortium, Bork P., Ehrlich S.D., Wang J. (2010) A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464:.5965.
  • 4
    Deguchi Y., Morishita T., Mutai M. (1985) Comparative studies of water soluble vitamins among human species of bifidobacteria. Agric Biol Chem 49:139.
  • 5
    Kim J.E., Kim J.Y., Lee K.W., Lee H.J. (2007) Cancer chemopreventive effects of lactic acid bacteria. J Microbiol Biotechnol 17:122735.
  • 6
    Pompei A., Cordisco L., Amaretti A., Zanoni S., Matteuzzi D., Rossi M. (2007) Folate production by bifidobacteria as a potential probiotic property. Appl Environ Microbiol 73:17985.
  • 7
    de Vrese M., Schrezenmeir J. (2008) Probiotics, prebiotics, and synbiotics. Adv Biochem Eng Biotechnol 111:166.
  • 8
    Fukuda S., Toh H., Hase K., Oshima K., Nakanishi Y., Yoshimura K., Tobe T., Clarke J.M., Topping D.L., Suzuki T., Taylor T.D., Itoh K., Kikuchi J., Morita H., Hattori M., Ohno H. (2011) Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 469:5437.
  • 9
    Mimura T., Rizzello F., Helwig U., Poggioli G., Schreiber S., Talbot I.C., Nicholls R.J., Gionchetti P., Campieri M., Kamm M.A. (2004) Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 53:10814.
  • 10
    Furrie E., Macfarlane S., Kennedy A., Cummings J.H., Walsh S.V., O’neil D.A., Macfarlane G.T. (2005) Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial. Gut 54:2429.
  • 11
    Miele E., Pascarella F., Giannetti E., Quaglietta L., Baldassano R.N., Staiano A. (2009) Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis. Am J Gastroenterol 104:43743.
  • 12
    O’Hara A.M., O’Regan P., Fanning A., O’Mahony C., Macsharry J., Lyons A., Bienenstock J., O’Mahony L., Shanahan F. (2006) Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius. Immunology 118:20215.
  • 13
    Riedel C.U., Foata F., Philippe D., Adolfsson O., Eikmanns B.J., Blum S. (2006) Anti-inflammatory effects of bifidobacteria by inhibition of LPS-induced NF-kappaB activation. World J Gastroenterol 12:372935.
  • 14
    Heuvelin E., Lebreton C., Grangette C., Pot B., Cerf-Bensussan N., Heyman M. (2009) Mechanisms involved in alleviation of intestinal inflammation by Bifidobacterium breve soluble factors. PLoS One, No. DOI: http://dx.doi.org/10.137110.1371http://dx.doi.org//journal.pone.0005184/journal.pone.0005184
  • 15
    Petrof E.O., Kojima K., Ropeleski M.J., Musch M.W., Tao Y., De Simone C., Chang E.B. (2004) Probiotics inhibit nuclear factor-kappaB and induce heat shock proteins in colonic epithelial cells through proteasome inhibition. Gastroenterology 127:147487.
  • 16
    Ménard S., Candalh C., Bambou J.C., Terpend K., Cerf-Bensussan N., Heyman M. (2004) Lactic acid bacteria secrete metabolites retaining anti-inflammatory properties after intestinal transport. Gut 53:8218.
  • 17
    Imaoka A., Shima T., Kato K., Mizuno S., Uehara T., Matsumoto S., Setoyama H., Hara T., Umesaki Y. (2008) Anti-inflammatory activity of probiotic Bifidobacterium: enhancement of IL-10 production in peripheral blood mononuclear cells from ulcerative colitis patients and inhibition of IL-8 secretion in HT-29 cells. World J Gastroenterol 14:25116.
  • 18
    Frick J.S., Fink K., Kahl F., Niemiec M.J., Quitadamo M., Schenk K., Autenrieth I.B. (2007) Identification of commensal bacterial strains that modulate Yersinia enterocolitica and dextran sodium sulfate-induced inflammatory responses: implications for the development of probiotics. Infect Immun 75:34907.
  • 19
    Ghadimi D., Vrese M., Heller K.J., Schrezenmeir J. (2010) Effect of natural commensal-origin DNA on toll-like receptor 9 (TLR9) signaling cascade, chemokine IL-8 expression, and barrier integrity of polarized intestinal epithelial cells. Inflamm Bowel Dis 16:41027.
  • 20
    Medina M., Izquierdo E., Ennahar S., Sanz Y. (2007) Differential immunomodulatory properties of Bifidobacterium longum strains: relevance to probiotic selection and clinical applications. Clin Exp Immunol 150:5318.
  • 21
    Park S.Y., Ji G.E., Ko Y.T., Jung H.K., Ustunol Z., Pestka J.J. (1999) Potentiation of hydrogen peroxide, nitric oxide, and cytokine production in RAW 264.7 macrophage cells exposed to human and commercial isolates of Bifidobacterium. Int J Food Microbiol 46:23141.
  • 22
    He F., Morita H., Ouwehand A.C., Hosoda M., Hiramatsu M., Kurisaki J., Isolauri E., Benno Y., Salminen S. (2002) Stimulation of the secretion of pro-inflammatory cytokines by Bifidobacterium strains. Microbiol Immunol 46:7815.
  • 23
    López P., Gueimonde M., Margolles A., Suárez A. (2010) Distinct Bifidobacterium strains drive different immune responses in vitro. Int J Food Microbiol 138:15765.
  • 24
    Young S.L., Simon M.A., Baird M.A., Tannock G.W., Bibiloni R., Spencely K., Lane J.M., Fitzharris P., Crane J., Town I., Addo-Yobo E., Murray C.S., Woodcock A. (2004) Bifidobacterial species differentially affect expression of cell surface markers and cytokines of dendritic cells harvested from cord blood. Clin Diagn Lab Immunol 11:68690.
  • 25
    Preising J., Philippe D., Gleinser M., Wei H., Blum S., Eikmanns B.J., Niess J.H., Riedel C.U. (2010) Selection of bifidobacteria based on adhesion and anti-inflammatory capacity in vitro for amelioration of murine colitis. Appl Environ Microbiol 76:304851.
  • 26
    Sambrook J., Russell D.W. (2001) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor , NY : Cold Spring Harbor Laboratory Press.
  • 27
    Kim S.W., Kim H.M., Yang K.M., Kim S.A., Kim S.K., An M.J., Park J.J., Lee S.K., Kim T.I., Kim W.H., Cheon J.H. (2010) Bifidobacterium lactis inhibits NF-kappaB in intestinal epithelial cells and prevents acute colitis and colitis-associated colon cancer in mice. Inflamm Bowel Dis 16:151425.
  • 28
    Fukushima K., Sasaki I., Ogawa H., Naito H., Funayama Y., Matsuno S. (1999) Colonization of microflora in mice: mucosal defense against luminal bacteria. J Gastroenterol 34:5460.
  • 29
    Ayabe T., Satchell D.P., Wilson C.L., Parks W.C., Selsted M.E., Ouellette A.J. (2000) Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria. Nat Immunol 1:1138.
  • 30
    Macpherson A.J., Gatto D., Sainsbury E., Harriman G.R., Hengartner H., Zinkernagel R.M. (2000) A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria. Science 288:22226.
  • 31
    Hooper L.V., Wong M.H., Thelin A., Hansson L., Falk P.G., Gordon J.I. (2001) Molecular analysis of commensal host-microbial relationships in the intestine. Science 291:8814.
  • 32
    Mueller C., Macpherson A.J. (2006) Layers of mutualism with commensal bacteria protect us from intestinal inflammation. Gut 55:27684.
  • 33
    Di Giacinto C., Marinaro M., Sanchez M., Strober W., Boirivant M. (2005) Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells. J Immunol 174:323746.
  • 34
    Chowdhury S.R., King D.E., Willing B.P., Band M.R., Beever J.E., Lane A.B., Loor J.J., Marini J.C., Rund L.A., Schook L.B., Van Kessel A.G., Gaskins H.R. (2007) Transcriptome profiling of the small intestinal epithelium in germfree versus conventional piglets. BMC Genomics, No. DOI:http://dx.doi.org/10.118610.1186http://dx.doi.org/1471-2164-8-215/1471-2164-8-215.
  • 35
    Otte J.M., Podolsky D.K. (2004) Functional modulation of enterocytes by Gram-positive and Gram-negative microorganisms. Am J Physiol Gastrointest Liver Physiol 286:61326.
  • 36
    Park M.S., Kim M.J., Ji G.E. (2007) Assessment of lipopolysaccharide-binding activity of Bifidobacterium and its relationship with cell surface hydrophobicity, autoaggregation, and inhibition of interleukin-8 production. J Microbiol Biotechnol 17:11206.
  • 37
    Roselli M., Finamore A., Britti M.S., Mengheri E. (2006) Probiotic bacteria Bifidobacterium animalis MB5 and Lactobacillus rhamnosus GG protect intestinal Caco-2 cells from the inflammation-associated response induced by enterotoxigenic Escherichia coli K88. Br J Nutr 95:117784.
  • 38
    Hoarau C., Lagaraine C., Martin L., Velge-Roussel F., Lebranchu Y. (2006) Supernatant of Bifidobacterium breve induces dendritic cell maturation, activation, and survival through a Toll-like receptor 2 pathway. J Allergy Clin Immunol 117:696702.
  • 39
    Ewaschuk J.B., Diaz H., Meddings L., Diederichs B., Dmytrash A., Backer J., Looijer-van Langen M., Madsen K.L. (2008) Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function. Am J Physiol Gastrointest Liver Physiol 295:G102534.
  • 40
    Bai A.P., Ouyang Q., Zhang W., Wang C.H., Li S.F. (2004) Probiotics inhibit TNF-alpha-induced interleukin-8 secretion of HT29 cells. World J Gastroenterol 10:4557.
  • 41
    Sibartie S., O’Hara A.M., Ryan J., Fanning A., O’Mahony J., O’Neill S., Sheil B., O’Mahony L., Shanahan F. (2009) Modulation of pathogen-induced CCL20 secretion from HT-29 human intestinal epithelial cells by commensal bacteria. BMC Immunol, No. DOI:http://dx.doi.org/10.118610.1186http://dx.doi.org/1471-2172-10-54/1471-2172-10-54.
  • 42
    Broekaert I.J., Nanthakumar N.N., Walker W.A. (2007) Secreted probiotic factors ameliorate enteropathogenic infection in zinc-deficient human Caco-2 and T84 cell lines. Pediatr Res 62:13944.
  • 43
    Ewaschuk J.B., Walker J.W., Diaz H., Madsen K.L. (2006) Bioproduction of conjugated linoleic acid by probiotic bacteria occurs in vitro and in vivo in mice. J Nutr 136:14837.
  • 44
    Neish A.S., Gewirtz A.T., Zeng H., Young A.N., Hobert M.E., Karmali V., Rao A.S., Madara J.L. (2000) Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination. Science 289:15603.
  • 45
    Tien M.T., Girardin S.E., Regnault B., Le Bourhis L., Dillies M.A., Coppée J.Y., Bourdet-Sicard R., Sansonetti P.J., Pédron T. (2006) Anti-inflammatory effect of Lactobacillus casei on Shigella-infected human intestinal epithelial cells. J Immunol 176:122837.
  • 46
    Kelly D., Campbell J.I., King T.P., Grant G., Jansson E.A., Coutts A.G., Pettersson S., Conway S. (2004) Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat Immunol 5:10412.
  • 47
    Hoermannsperger G., Clavel T., Hoffmann M., Reiff C., Kelly D., Loh G., Blaut M., Hölzlwimmer G., Laschinger M., Haller D. (2009) Post-translational inhibition of IP-10 secretion in IEC by probiotic bacteria: impact on chronic inflammation. PLoS One, No. DOI:http://dx.doi.org/10.137110.1371 http://dx.doi.org/journal.pone.0004365/journal.pone.0004365.
  • 48
    Totzke G., Essmann F., Pohlmann S., Lindenblatt C., Jänicke R.U., Schulze-Osthoff K. (2006) A novel member of the IkappaB family, human IkappaB-zeta, inhibits transactivation of p65 and its DNA binding. J Biol Chem 281:1264554.
  • 49
    Prud’homme G.J. (2007) Pathobiology of transforming growth factor beta in cancer, fibrosis and immunologic disease, and therapeutic considerations. Lab Invest 87:107791.
  • 50
    Haller D., Bode C., Hammes W.P., Pfeifer A.M., Schiffrin E.J., Blum S. (2000) Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leucocyte co-cultures. Gut 47:7987.
  • 51
    Grimoud J., Durand H., de Souza S., Monsan P., Ouarné F., Theodorou V., Roques C. (2010) In vitro screening of probiotics and synbiotics according to anti-inflammatory and anti-proliferative effects. Int J Food Microbiol 144:4250.